PTC Therapeutics
PTCT • NASDAQ
PTC Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Klein, with a market cap of $5.9B.
Market Cap$5.9B
Employees995.0
CEOMatthew Klein
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
PTC Therapeutics FAQ
Common questions about PTC Therapeutics
PTC Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026 after market close. Analysts estimate revenue of $224.4M.
PTC Therapeutics has approximately 995 employees.